Ibarakihigashi National Hospital

Ibaraki 319-1113

0 studies enrolling now · 2 studies all time

What they study most

Asthma, MAC Lung Disease, Mycobacterium Infections, Nontuberculous, Treatment Refractory MAC Lung Disease

Studies at this site

• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed